A PILOT STUDY TO EVALUATE THE ROLE OF 68Ga-PSMA PET/CT (RADIOLOGICAL INVESTIGATION) IN PATIENTS WITH JUVENILE NASAL ANGIOFIBROMA

A PILOT STUDY TO EVALUATE THE ROLE OF 68Ga-PSMA-HBED-CC PET/CT IN PATIENTS WITH JUVENILE NASAL ANGIOFIBROMA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015479

Enrollment

Registered

2018-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D140- Benign neoplasm of middle ear, nasal cavity and accessory sinuses Health Condition 2: null- Juvenile nasal angiofibroma

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: All clinicoradiologicaly suspected primary cases of JNA (as biopsy is contraindicated) 1. All histopathologically proven cases of JNA who are on follow up and undergoing CEMRI scan for routine surveillance 2. Both treatment naive and treated patients will be included

Exclusion criteria

Exclusion criteria: 1. Patients refusing consent for the procedure 2. Patients with deranged LFT ( Bilirubin >1.5mg%), deranged RFT (S. Creatinine >1.2)

Design outcomes

Primary

Measure	Time frame
Expected to have uptake in the tumorTimepoint: six months	—

Secondary

Measure	Time frame
To know the intensity and pattern of uptake of PSMA tracerTimepoint: one year	—

Countries

India

Contacts

Public ContactPirabu Sakthivel

All India Institute of Medical Sciences

pirabusakthivel@gmail.com09958744547

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 22, 2026